Product Name: tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate CAS NO:877399-73-0
Chemical & Physical Properties:
Appearance :white powder
Boiling Point:430.596℃ at 760 mmHg
On February 25, 2013, Pfizer announced that XALKORI (crizotinib) capsules have recently been approved by the State Food and Drug Administration (SFDA) of China, which is the first test method approved by the SFDA Drugs for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that are positive for anaplastic lymphoma kinase (ALK).
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.